CClinicalTrials.gg
Not yet recruitingNCT06697795Updated Nov 20, 2024

Cost-Effectiveness Analysis of a Virtual Reality-Assisted Hypnotherapy Program on Quality of Life in Patients with Chronic Neck Pain: a Multicenter, Randomized, Prospective, Comparative, Open-Label, Parallel-Group Study

An interventional study of Virtual Reality-Assisted Hypnotherapy and Standard Physical Therapy in Chronic Neck Pain and Neck Pain, sponsored by University of Beykent. Not yet recruiting at 1 site in Turkey. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-11-20.

Sponsored by University of Beykent · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

This randomized, prospective study aims to evaluate the effectiveness and cost-efficiency of a Virtual Reality (VR)-assisted hypnotherapy program on quality of life in patients with chronic neck pain. The study compares a VR-assisted hypnotherapy group to a standard treatment group. Both groups will undergo a conventional physical therapy program supervised by physiotherapists for 3 weeks (15 sessions). The VR-assisted hypnotherapy group will receive additional sessions utilizing the HypnoVR software, which delivers relaxing virtual environments. Outcomes will be assessed immediately after treatment, at 1 month, and at 3 months post-treatment. Primary endpoints include pain reduction measured by the Visual Analog Scale (VAS). Secondary endpoints include functionality, quality of life, anxiety, depression, sleep quality, healthcare costs, and treatment adherence. Statistical analyses will determine the efficacy and economic impact of this innovative therapy for chronic neck pain management.

02

Conditions studied

  • Chronic Neck Pain
  • Neck Pain

Browse trials for

Keywords

  • hypnotherapy
  • virtual reality
03

In context

Neck Pain

1,233 studies on the registry are indexed under Neck Pain; 256 are open to participants now.

This study's planned enrollment of 60 is above the median of 51 across 1,005 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

University of Beykent is the lead sponsor of 54 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 50 and 80 years.
  • Chronic neck pain lasting for more than 3 months.

Exclusion criteria

Exclusion Criteria:

  • History of spinal surgery.
  • Beck Depression Inventory (BDI) score >16.
  • Presence of neurological deficits or concurrent neurological diseases.
  • Medical conditions incompatible with the use of VR headsets (e.g., vision problems, epilepsy).
  • Pregnancy.
  • Recent changes in medication for chronic pain within the past 3 months (e.g.,- Pregabalin, Gabapentin, Duloxetine).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Virtual Reality-Assisted Hypnotherapy+Physiotherapy Group

    Participants in this arm will undergo a conventional physical therapy program for 3 weeks (15 sessions) supervised by physiotherapists. Additionally, during each physical therapy session, participants will receive a 20-minute Virtual Reality (VR)-assisted hypnotherapy session using the HypnoVR software.

    Device: Virtual Reality-Assisted Hypnotherapy

  • Active comparator
    Standard Treatment Group

    Participants in this arm will undergo a conventional physical therapy program for 3 weeks (15 sessions) supervised by physiotherapists.

    Other: Standard Physical Therapy

Interventions

  • DeviceVirtual Reality-Assisted Hypnotherapy

    Virtual Reality-Assisted Hypnotherapy utilizes HypnoVR software delivered through VR glasses to provide a relaxing virtual environment. The intervention is integrated into a standard physical therapy program, with participants receiving 20-minute VR-assisted hypnotherapy sessions during each of the 15 supervised physical therapy sessions over a 3-week period. This approach aims to improve pain management, quality of life, and adherence to treatment in patients with chronic neck pain.

  • OtherStandard Physical Therapy

    Participants in the control group will undergo a standard physical therapy program focused on the cervical region, consisting of 15 sessions over 3 weeks. Each session will be supervised by physiotherapists in a clinical setting and will include traditional physical therapy techniques such as therapeutic exercises

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity

    The primary outcome is the percentage change in pain intensity, measured using the Visual Analog Scale (VAS). A reduction of ≥30% in the VAS score from baseline is considered clinically significant.

    Time frame: Assessed at baseline, immediately after treatment (3 weeks), and at 1- and 3-month follow-ups.

Secondary outcomes

  1. Change in Functional Status

    Functional status will be assessed using the Neck Disability Index (NDI). Improvement in NDI scores reflects better functionality and reduced disability related to chronic neck pain.

    Time frame: Baseline, post-treatment (3 weeks), and at 1- and 3-month follow-ups.

  2. Change in Quality of Life

    Quality of life will be measured using the Short Form-12 (SF-12) questionnaire.

    Time frame: Baseline, post-treatment (3 weeks), and at 1- and 3-month follow-ups.

  3. Reduction in Analgesic Use

    The number of days per week participants use nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen for pain management will be recorded.

    Time frame: Baseline and weekly throughout the 3-month follow-up period.

  4. Change in Anxiety and Depression Levels

    Anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS).

    Time frame: Baseline, post-treatment (3 weeks), and at 1- and 3-month follow-ups.

  5. Reduction in Healthcare Utilization

    Healthcare utilization, including the number of clinic visits (Family Medicine, Physical Therapy, Orthopedics) and cervical imaging (X-ray, MRI), will be recorded for the 3 months prior to and after the intervention.

    Time frame: Assessed retrospectively at baseline and at the 3-month follow-up.

07

Study locations

1 site
  • Beykent University Faculty of Medicine, Physical Therapy Unit
    Istanbul, Turkey
08

References and documents

Related links

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06697795
Lead sponsor
University of Beykent
Responsible party
TUĞBA ŞAHBAZ (Associate Professor, University of Beykent) — Principal investigator
First posted
Nov 20, 2024
Start date
Dec 2, 2024 (estimated)
Primary completion
Apr 1, 2025 (estimated)
Completion
Jul 1, 2025 (estimated)
Last update
Nov 20, 2024

Study contacts

Tugba Sahbaz, Associate Professor
Contact
piskint@gmail.com
+90444 1997 ext. 6021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion